The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children

The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children

Abstract Background Trauma is the leading cause of death and disability in children in the USA. Tranexamic acid (TXA) reduces the blood transfusion requirements in adults and children during surgery. Several studies have evaluated TXA in adults with hemorrhagic trauma, but no randomized controlled t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: John M. VanBuren, T. Charles Casper, Daniel K. Nishijima, Nathan Kuppermann, Roger J. Lewis, J. Michael Dean, Anna McGlothlin, For the TIC-TOC Collaborators of the Pediatric Emergency Care Applied Research Network (PECARN)
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Bayesian statistics
Tranexamic acid
Pediatrics
Adaptive clinical trial design
Response-adaptive randomization
Dose-response
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/1cc18e06b8e348a38442702dd6d5bb1c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/1cc18e06b8e348a38442702dd6d5bb1c

Ejemplares similares